Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for AXSM

Stock Name	Axsome Therapeutics Inc
Ticker	AXSM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US05464T1043
LEI	549300EXGR0XLRJEIB95

Show aggregate AXSM holdings

News associated with AXSM

Peek Under The Hood: JHMM Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:11:32
Roger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock: Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) Director Roger Jeffs sold 13,464 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $123.68, for a total value of $1,665,227.52. Following the completion of the sale, the director owned 57,510 shares in […] - 2025-09-04 05:23:00
Deutsche Bank AG Lowers Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Deutsche Bank AG reduced its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 21.2% during the first quarter, Holdings Channel reports. The institutional investor owned 94,980 shares of the company’s stock after selling 25,567 shares during the period. Deutsche Bank AG’s holdings in Axsome Therapeutics were worth $11,078,000 as of its […] - 2025-08-15 05:17:09
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $189.00 at Royal Bank Of Canada: Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective increased by analysts at Royal Bank Of Canada from $184.00 to $189.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective suggests a potential upside of 83.03% from the […] - 2025-08-07 05:30:53
KLP Kapitalforvaltning AS Decreases Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM): KLP Kapitalforvaltning AS reduced its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.8% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,200 shares of the company’s stock after selling 600 shares during the period. KLP Kapitalforvaltning AS’s holdings in Axsome Therapeutics were worth […] - 2025-07-29 05:28:50
Cerity Partners LLC Raises Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Cerity Partners LLC lifted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 15.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 5,707 shares of the company’s stock after purchasing an additional 766 shares during the period. Cerity Partners LLC’s holdings in Axsome Therapeutics were worth $666,000 as of […] - 2025-07-25 04:50:58
12,745 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Acquired by Y Intercept Hong Kong Ltd: Y Intercept Hong Kong Ltd purchased a new stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund purchased 12,745 shares of the company’s stock, valued at approximately $1,486,000. A number of other hedge funds have also recently made changes to their positions in AXSM. HighTower Advisors LLC […] - 2025-07-24 06:02:49
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by New York State Common Retirement Fund: New York State Common Retirement Fund raised its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 49.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,581 shares of the company’s stock after buying an additional 11,090 […] - 2025-07-22 07:13:06
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,623 shares of the company’s stock after acquiring an additional 136 […] - 2025-07-17 05:39:38
D.A. Davidson & CO. Has $788,000 Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM): D.A. Davidson & CO. reduced its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 17.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,755 shares of the company’s stock after selling 1,475 shares during the quarter. D.A. Davidson […] - 2025-07-10 05:31:08
Head-To-Head Review: Axsome Therapeutics (NASDAQ:AXSM) vs. Rosetta Genomics (OTCMKTS:ROSGQ): Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) and Rosetta Genomics (OTCMKTS:ROSGQ – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Risk and Volatility Axsome Therapeutics has a beta […] - 2025-07-07 02:28:50
Janney Montgomery Scott LLC Has $1.74 Million Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Janney Montgomery Scott LLC raised its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 8.6% in the 1st quarter, HoldingsChannel reports. The fund owned 14,923 shares of the company’s stock after buying an additional 1,178 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Axsome Therapeutics were worth $1,740,000 at the end […] - 2025-06-27 04:26:52
AXSM Makes Notable Cross Below Critical Moving Average: In trading on Monday, shares of Axsome Therapeutics Inc (Symbol: AXSM) crossed below their 200 day moving average of $102.28, changing hands as low as $101.01 per share. Axsome Therapeutics Inc shares are currently trading down about 1.9% on the day. The chart below shows the - 2025-06-16 12:41:26
GAMMA Investing LLC Increases Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): GAMMA Investing LLC increased its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 38,571.9% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,043 shares of the company’s stock after buying an additional 21,986 shares during the quarter. GAMMA Investing […] - 2025-06-13 05:14:47
Rhumbline Advisers Grows Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Rhumbline Advisers boosted its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 54,760 shares of the company’s stock after acquiring an additional 3,515 shares during the quarter. Rhumbline Advisers’ holdings in Axsome Therapeutics […] - 2025-06-12 05:31:01
HC Wainwright Reiterates “Buy” Rating for Axsome Therapeutics (NASDAQ:AXSM): Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They currently have a $180.00 target price on the stock. HC Wainwright’s price target would suggest a potential upside of 66.54% from the stock’s previous close. Several other […] - 2025-06-12 02:18:55
Needham & Company LLC Cuts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $150.00: Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective decreased by Needham & Company LLC from $153.00 to $150.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 36.48% from the […] - 2025-06-11 02:44:51
2 Soaring Stocks Wth More Upside Potential: Although fundamental investing wisdom tells us to "buy low," it may still be worthwhile to purchase shares of top companies following significant runs. Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to Summit - 2025-06-05 04:19:00
Nuveen Asset Management LLC Increases Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Nuveen Asset Management LLC raised its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 118.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 221,202 shares of the company’s stock after acquiring an additional 119,780 shares during the period. Nuveen Asset Management LLC’s holdings in Axsome Therapeutics were worth $18,716,000 as of its […] - 2025-05-25 06:03:20
Captrust Financial Advisors Sells 2,769 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM): Captrust Financial Advisors decreased its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 48.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,953 shares of the company’s stock after selling 2,769 shares during the period. Captrust Financial Advisors’ holdings in Axsome Therapeutics […] - 2025-05-22 04:47:00
Comerica Bank Sells 3,570 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM): Comerica Bank trimmed its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 32.6% during the 4th quarter, HoldingsChannel reports. The firm owned 7,374 shares of the company’s stock after selling 3,570 shares during the quarter. Comerica Bank’s holdings in Axsome Therapeutics were worth $624,000 at the end of the most recent reporting period. […] - 2025-05-15 04:52:49
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $162.00: Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its target price lifted by Robert W. Baird from $160.00 to $162.00 in a report released on Tuesday, Marketbeat reports. Robert W. Baird currently has an outperform rating on the stock. Other research analysts have also recently issued research reports about the company. HC Wainwright reaffirmed a “buy” […] - 2025-05-09 03:56:43
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by Price T Rowe Associates Inc. MD: Price T Rowe Associates Inc. MD raised its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 12.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 31,228 shares of the company’s stock after acquiring an additional 3,366 shares during the period. Price T Rowe Associates […] - 2025-05-07 05:50:49
Axsome Therapeutics (NASDAQ:AXSM) Trading Up 5.6% After Earnings Beat: Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report)’s stock price was up 5.6% during trading on Monday following a better than expected earnings announcement. The stock traded as high as $117.60 and last traded at $118.54. Approximately 231,459 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 683,737 […] - 2025-05-07 02:24:42
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 10:32:49
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 08:45:35
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 06:31:04
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 03:51:04
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 02:59:18
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 01:28:32

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) AXSM holdings

Date	Number of AXSM Shares Held	Base Market Value of AXSM Shares	Local Market Value of AXSM Shares	Change in AXSM Shares Held	Change in AXSM Base Value	Current Price per AXSM Share Held	Previous Price per AXSM Share Held
2025-11-12 (Wednesday)	32,367	USD 4,559,216	USD 4,559,216	83	USD 52,047	USD 140.86	USD 139.61
2025-11-11 (Tuesday)	32,284	USD 4,507,169	USD 4,507,169	0	USD 58,434	USD 139.61	USD 137.8
2025-11-10 (Monday)	32,284	USD 4,448,735	USD 4,448,735	82	USD 29	USD 137.8	USD 138.15
2025-11-07 (Friday)	32,202	USD 4,448,706	USD 4,448,706	0	USD -40,575	USD 138.15	USD 139.41
2025-11-06 (Thursday)	32,202	USD 4,489,281	USD 4,489,281	82	USD 130,918	USD 139.41	USD 135.69
2025-11-05 (Wednesday)	32,120	USD 4,358,363	USD 4,358,363	0	USD 24,411	USD 135.69	USD 134.93
2025-11-04 (Tuesday)	32,120	USD 4,333,952	USD 4,333,952	83	USD -15,071	USD 134.93	USD 135.75
2025-11-03 (Monday)	32,037	USD 4,349,023	USD 4,349,023	0	USD 24,348	USD 135.75	USD 134.99
2025-10-31 (Friday)	32,037	USD 4,324,675	USD 4,324,675	0	USD 58,948	USD 134.99	USD 133.15
2025-10-30 (Thursday)	32,037	USD 4,265,727	USD 4,265,727	415	USD 49,566	USD 133.15	USD 133.33
2025-10-29 (Wednesday)	31,622	USD 4,216,161	USD 4,216,161	166	USD 16,470	USD 133.33	USD 133.51
2025-10-28 (Tuesday)	31,456	USD 4,199,691	USD 4,199,691	0	USD -36,803	USD 133.51	USD 134.68
2025-10-27 (Monday)	31,456	USD 4,236,494	USD 4,236,494	0	USD 161,369	USD 134.68	USD 129.55

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AXSM by Blackrock for IE00BYXG2H39

Show aggregate share trades of AXSM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 BUY 83 144.150 139.700 140.145 USD 11,632 111.21
2025-11-10 BUY 82 140.380 137.035 137.370 USD 11,264 110.93
2025-11-06 BUY 82 141.360 133.010 133.845 USD 10,975 110.65
2025-11-04 BUY 83 136.100 131.510 131.969 USD 10,953 110.40
2025-10-30 BUY 415 136.125 131.011 131.522 USD 54,582 110.02
2025-10-29 BUY 166 133.330 134.910 134.752 USD 22,369 109.89
2025-10-22 SELL -332 129.720 131.745 131.542 USD -43,672 109.32 Loss of -7,376 on sale
2025-10-20 BUY 166 131.600 134.360 134.084 USD 22,258 109.08
2025-10-17 BUY 414 127.940 128.225 128.197 USD 53,073 108.98
2025-10-15 BUY 656 129.580 130.350 130.273 USD 85,459 108.87
2025-10-03 BUY 574 120.300 122.140 121.956 USD 70,003 108.72
2025-10-02 BUY 82 119.940 120.800 120.714 USD 9,899 108.66
2025-09-30 BUY 164 121.450 121.470 121.468 USD 19,921 108.53
2025-09-26 BUY 164 116.760 117.836 117.728 USD 19,307 108.43
2025-09-25 BUY 164 116.010 118.990 118.692 USD 19,465 108.38
2025-09-24 SELL -1,018 118.770 119.040 119.013 USD -121,155 108.32 Loss of -10,882 on sale
2025-09-18 BUY 85 118.630 118.770 118.756 USD 10,094 108.26
2025-09-17 BUY 255 116.620 118.432 118.251 USD 30,154 108.21
2025-08-20 SELL -340 116.990 117.130 117.116 USD -39,819 107.99 Loss of -3,102 on sale
2025-07-30 BUY 340 101.260 103.990 103.717 USD 35,264 108.06
2025-07-17 SELL -170 112.240 113.500 113.374 USD -19,274 108.22 Loss of -877 on sale
2025-07-16 BUY 299 111.320 112.620 112.490 USD 33,635 108.19
2025-07-11 SELL -672 108.980 112.210 111.887 USD -75,188 108.15 Loss of -2,513 on sale
2025-07-07 BUY 252 107.500 108.190 108.121 USD 27,246 108.10
2025-07-02 BUY 4,620 103.910 104.830 104.738 USD 483,890 108.15
2025-06-20 BUY 943 100.690 103.915 103.593 USD 97,688 108.21
2025-06-11 BUY 162 108.080 111.150 110.843 USD 17,957 108.43
2025-06-10 BUY 162 109.910 112.980 112.673 USD 18,253 108.42
2025-06-04 SELL -81 108.140 111.040 110.750 USD -8,971 108.36 Loss of -193 on sale
2025-04-23 BUY 81 104.230 106.050 105.868 USD 8,575 108.56
2025-04-10 SELL -648 95.650 99.565 99.174 USD -64,264 109.19 Profit of 6,490 on sale
2025-04-08 SELL -81 97.550 103.000 102.455 USD -8,299 109.41 Profit of 563 on sale
2025-04-07 SELL -81 98.500 102.200 101.830 USD -8,248 109.54 Profit of 624 on sale
2025-04-04 SELL -405 98.860 106.285 105.543 USD -42,745 109.66 Profit of 1,668 on sale
2025-04-01 BUY 705 111.670 113.735 113.529 USD 80,038 109.64
2025-03-31 SELL -240 116.630 117.780 117.665 USD -28,240 109.55 Loss of -1,947 on sale
2025-03-21 BUY 1,185 126.790 128.500 128.329 USD 152,070 108.52
2025-03-14 SELL -1,216 121.910 123.470 123.314 USD -149,950 107.36 Loss of -19,395 on sale
2025-03-07 SELL -152 122.170 124.960 124.681 USD -18,952 106.38 Loss of -2,781 on sale
2025-03-04 SELL -76 125.570 127.224 127.059 USD -9,656 105.50 Loss of -1,639 on sale
2025-02-25 BUY 152 127.090 131.990 131.500 USD 19,988 103.62
2025-02-19 SELL -76 126.960 130.520 130.164 USD -9,892 101.58 Loss of -2,173 on sale
2025-02-13 BUY 228 131.680 132.135 132.089 USD 30,116 99.26
2025-02-12 BUY 76 131.550 133.100 132.945 USD 10,104 98.60
2025-02-11 BUY 304 132.200 134.185 133.986 USD 40,732 97.90
2024-12-30 SELL -2,481 84.780 84.980 84.960 USD -210,786 94.48 Profit of 23,630 on sale
2024-11-18 SELL -1,230 92.450 95.000 94.745 USD -116,536 90.65 Loss of -5,035 on sale
2024-11-08 SELL -82 90.070 91.370 91.240 USD -7,482 90.06 Loss of -97 on sale
2024-10-21 SELL -82 91.500 93.100 92.940 USD -7,621 0.00 Loss of -7,621 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	BUY	83	144.150	139.700	140.145	USD 11,632	111.21
2025-11-10	BUY	82	140.380	137.035	137.370	USD 11,264	110.93
2025-11-06	BUY	82	141.360	133.010	133.845	USD 10,975	110.65
2025-11-04	BUY	83	136.100	131.510	131.969	USD 10,953	110.40
2025-10-30	BUY	415	136.125	131.011	131.522	USD 54,582	110.02
2025-10-29	BUY	166	133.330	134.910	134.752	USD 22,369	109.89
2025-10-22	SELL	-332	129.720	131.745	131.542	USD -43,672	109.32 Loss of -7,376 on sale
2025-10-20	BUY	166	131.600	134.360	134.084	USD 22,258	109.08
2025-10-17	BUY	414	127.940	128.225	128.197	USD 53,073	108.98
2025-10-15	BUY	656	129.580	130.350	130.273	USD 85,459	108.87
2025-10-03	BUY	574	120.300	122.140	121.956	USD 70,003	108.72
2025-10-02	BUY	82	119.940	120.800	120.714	USD 9,899	108.66
2025-09-30	BUY	164	121.450	121.470	121.468	USD 19,921	108.53
2025-09-26	BUY	164	116.760	117.836	117.728	USD 19,307	108.43
2025-09-25	BUY	164	116.010	118.990	118.692	USD 19,465	108.38
2025-09-24	SELL	-1,018	118.770	119.040	119.013	USD -121,155	108.32 Loss of -10,882 on sale
2025-09-18	BUY	85	118.630	118.770	118.756	USD 10,094	108.26
2025-09-17	BUY	255	116.620	118.432	118.251	USD 30,154	108.21
2025-08-20	SELL	-340	116.990	117.130	117.116	USD -39,819	107.99 Loss of -3,102 on sale
2025-07-30	BUY	340	101.260	103.990	103.717	USD 35,264	108.06
2025-07-17	SELL	-170	112.240	113.500	113.374	USD -19,274	108.22 Loss of -877 on sale
2025-07-16	BUY	299	111.320	112.620	112.490	USD 33,635	108.19
2025-07-11	SELL	-672	108.980	112.210	111.887	USD -75,188	108.15 Loss of -2,513 on sale
2025-07-07	BUY	252	107.500	108.190	108.121	USD 27,246	108.10
2025-07-02	BUY	4,620	103.910	104.830	104.738	USD 483,890	108.15
2025-06-20	BUY	943	100.690	103.915	103.593	USD 97,688	108.21
2025-06-11	BUY	162	108.080	111.150	110.843	USD 17,957	108.43
2025-06-10	BUY	162	109.910	112.980	112.673	USD 18,253	108.42
2025-06-04	SELL	-81	108.140	111.040	110.750	USD -8,971	108.36 Loss of -193 on sale
2025-04-23	BUY	81	104.230	106.050	105.868	USD 8,575	108.56
2025-04-10	SELL	-648	95.650	99.565	99.174	USD -64,264	109.19 Profit of 6,490 on sale
2025-04-08	SELL	-81	97.550	103.000	102.455	USD -8,299	109.41 Profit of 563 on sale
2025-04-07	SELL	-81	98.500	102.200	101.830	USD -8,248	109.54 Profit of 624 on sale
2025-04-04	SELL	-405	98.860	106.285	105.543	USD -42,745	109.66 Profit of 1,668 on sale
2025-04-01	BUY	705	111.670	113.735	113.529	USD 80,038	109.64
2025-03-31	SELL	-240	116.630	117.780	117.665	USD -28,240	109.55 Loss of -1,947 on sale
2025-03-21	BUY	1,185	126.790	128.500	128.329	USD 152,070	108.52
2025-03-14	SELL	-1,216	121.910	123.470	123.314	USD -149,950	107.36 Loss of -19,395 on sale
2025-03-07	SELL	-152	122.170	124.960	124.681	USD -18,952	106.38 Loss of -2,781 on sale
2025-03-04	SELL	-76	125.570	127.224	127.059	USD -9,656	105.50 Loss of -1,639 on sale
2025-02-25	BUY	152	127.090	131.990	131.500	USD 19,988	103.62
2025-02-19	SELL	-76	126.960	130.520	130.164	USD -9,892	101.58 Loss of -2,173 on sale
2025-02-13	BUY	228	131.680	132.135	132.089	USD 30,116	99.26
2025-02-12	BUY	76	131.550	133.100	132.945	USD 10,104	98.60
2025-02-11	BUY	304	132.200	134.185	133.986	USD 40,732	97.90
2024-12-30	SELL	-2,481	84.780	84.980	84.960	USD -210,786	94.48 Profit of 23,630 on sale
2024-11-18	SELL	-1,230	92.450	95.000	94.745	USD -116,536	90.65 Loss of -5,035 on sale
2024-11-08	SELL	-82	90.070	91.370	91.240	USD -7,482	90.06 Loss of -97 on sale
2024-10-21	SELL	-82	91.500	93.100	92.940	USD -7,621	0.00 Loss of -7,621 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AXSM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	68,445	300	138,492	49.4%
2025-09-18	68,724	0	169,529	40.5%
2025-09-17	76,197	40	235,412	32.4%
2025-09-16	165,940	84	332,172	50.0%
2025-09-15	92,091	46	186,500	49.4%
2025-09-12	170,518	1,480	325,952	52.3%
2025-09-11	88,854	16	216,018	41.1%
2025-09-10	61,160	0	187,155	32.7%
2025-09-09	142,408	200	299,185	47.6%
2025-09-08	144,320	0	285,049	50.6%
2025-09-05	104,449	0	205,294	50.9%
2025-09-04	73,216	1,801	138,763	52.8%
2025-09-03	141,477	0	223,165	63.4%
2025-09-02	170,723	300	297,328	57.4%
2025-08-29	64,424	1,970	131,926	48.8%
2025-08-28	55,224	200	123,399	44.8%
2025-08-27	111,321	12	228,559	48.7%
2025-08-26	116,205	0	242,941	47.8%
2025-08-25	54,093	584	115,267	46.9%
2025-08-22	125,994	0	268,008	47.0%
2025-08-21	93,981	600	186,202	50.5%
2025-08-20	105,544	0	162,402	65.0%
2025-08-19	146,328	0	321,780	45.5%
2025-08-18	110,411	0	419,410	26.3%
2025-08-15	58,491	0	149,199	39.2%
2025-08-14	63,117	0	124,653	50.6%
2025-08-13	90,090	0	217,540	41.4%
2025-08-12	50,283	920	155,222	32.4%
2025-08-11	47,068	0	126,857	37.1%
2025-08-08	46,479	0	126,179	36.8%
2025-08-07	65,399	0	143,983	45.4%
2025-08-06	121,354	0	208,439	58.2%
2025-08-05	216,252	15	377,690	57.3%
2025-08-04	274,153	551	441,196	62.1%
2025-08-01	224,315	1,925	341,203	65.7%
2025-07-31	160,824	0	273,054	58.9%
2025-07-30	142,247	9	235,179	60.5%
2025-07-29	117,550	0	233,072	50.4%
2025-07-28	203,714	708	330,365	61.7%
2025-07-25	240,457	35	377,498	63.7%
2025-07-24	112,006	5	181,155	61.8%
2025-07-23	246,830	0	323,571	76.3%
2025-07-22	354,999	0	495,589	71.6%
2025-07-21	126,659	0	205,641	61.6%
2025-07-18	130,794	15	199,458	65.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE